Tissue Repair (ASX:TRP) Net Margin % : -1,293.43% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tissue Repair Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Tissue Repair's Net Income for the six months ended in Dec. 2024 was A$-2.56 Mil. Tissue Repair's Revenue for the six months ended in Dec. 2024 was A$0.20 Mil. Therefore, Tissue Repair's net margin for the quarter that ended in Dec. 2024 was -1,293.43%.

The historical rank and industry rank for Tissue Repair's Net Margin % or its related term are showing as below:

ASX:TRP' s Net Margin % Range Over the Past 10 Years
Min: -139133.33 Med: -70927.85 Max: -1521.23
Current: -1521.23

ASX:TRP's Net Margin % is ranked worse than
79.48% of 999 companies
in the Biotechnology industry
Industry Median: -131.37 vs ASX:TRP: -1521.23

Tissue Repair Net Margin % Historical Data

The historical data trend for Tissue Repair's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Repair Net Margin % Chart

Tissue Repair Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Net Margin %

-139,133.33

-2,722.37

Tissue Repair Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Margin %	Get a 7-Day Free Trial			-	-	-3,825.42	-2,001.06	-1,293.43

Competitive Comparison of Tissue Repair's Net Margin %

For the Biotechnology subindustry, Tissue Repair's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Repair's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Repair's Net Margin % distribution charts can be found below:

* The bar in red indicates where Tissue Repair's Net Margin % falls into.

Save Embed

;

Save Embed

;

Tissue Repair Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Tissue Repair's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-4.138	/	0.152
	=	-2,722.37 %

Tissue Repair's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-2.561	/	0.198
	=	-1,293.43 %

Tissue Repair (ASX:TRP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Tissue Repair Net Margin % Related Terms

Thank you for viewing the detailed overview of Tissue Repair's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Repair Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Repair Ltd (ASX:TRP) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

255 Pitt Street, Level 10, Sydney, NSW, AUS, 2000

Website

https://www.tissuerepair.com.au

Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.